Vivo Capital as of Dec. 31, 2018
Portfolio Holdings for Vivo Capital
Vivo Capital holds 45 positions in its portfolio as reported in the December 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ascendis Pharma A S (ASND) | 17.3 | $136M | 2.2M | 62.65 | |
| Crinetics Pharmaceuticals In (CRNX) | 14.5 | $114M | 3.8M | 29.99 | |
| Biohaven Pharmaceutical Holding | 8.6 | $67M | 1.8M | 36.98 | |
| Codexis (CDXS) | 5.8 | $45M | 2.7M | 16.70 | |
| Sinovac Biotech (SVA) | 5.2 | $41M | 5.9M | 6.94 | |
| Arrowhead Pharmaceuticals (ARWR) | 3.7 | $29M | 2.3M | 12.42 | |
| Kalvista Pharmaceuticals (KALV) | 3.4 | $27M | 1.4M | 19.75 | |
| Homology Medicines | 3.3 | $26M | 1.2M | 22.36 | |
| Kadmon Hldgs | 2.8 | $22M | 11M | 2.08 | |
| Amyris | 2.4 | $19M | 5.6M | 3.34 | |
| Tricida | 2.4 | $18M | 781k | 23.57 | |
| Eiger Biopharmaceuticals | 2.3 | $18M | 1.8M | 10.16 | |
| Menlo Therapeutics | 2.1 | $17M | 4.0M | 4.12 | |
| Mei Pharma | 1.9 | $15M | 5.8M | 2.64 | |
| Iovance Biotherapeutics (IOVA) | 1.8 | $14M | 1.6M | 8.85 | |
| Verona Pharma Plc ads (VRNA) | 1.7 | $13M | 1.5M | 9.00 | |
| Orchard Therapeutics Plc ads | 1.6 | $13M | 812k | 15.73 | |
| Aclaris Therapeutics (ACRS) | 1.6 | $12M | 1.6M | 7.39 | |
| Obseva Sa | 1.5 | $12M | 937k | 12.66 | |
| Acer Therapeutics | 1.5 | $12M | 579k | 20.12 | |
| Apellis Pharmaceuticals (APLS) | 1.5 | $12M | 875k | 13.19 | |
| Mirati Therapeutics | 1.4 | $11M | 251k | 42.42 | |
| Nabriva Therapeutics | 1.2 | $9.7M | 6.6M | 1.46 | |
| Zymeworks | 1.2 | $9.1M | 620k | 14.68 | |
| Xenon Pharmaceuticals (XENE) | 1.1 | $8.9M | 1.4M | 6.31 | |
| Aurinia Pharmaceuticals (AUPH) | 1.1 | $8.3M | 1.2M | 6.82 | |
| Soleno Therapeutics | 0.9 | $7.5M | 4.4M | 1.71 | |
| Kiniksa Pharmaceuticals | 0.9 | $7.4M | 265k | 28.09 | |
| Cymabay Therapeutics | 0.9 | $7.1M | 906k | 7.87 | |
| Galmed Pharmaceuticals | 0.8 | $6.6M | 971k | 6.83 | |
| Kala Pharmaceuticals | 0.7 | $5.1M | 1.0M | 4.89 | |
| Zogenix | 0.5 | $3.8M | 105k | 36.46 | |
| Sierra Oncology | 0.4 | $3.2M | 2.4M | 1.32 | |
| Arvinas Ord (ARVN) | 0.3 | $2.7M | 210k | 12.85 | |
| Genocea Biosciences | 0.3 | $2.4M | 8.2M | 0.29 | |
| Zai Lab (ZLAB) | 0.2 | $1.9M | 82k | 23.22 | |
| Biopharmx | 0.2 | $1.8M | 16M | 0.11 | |
| Dbv Technologies S A | 0.2 | $1.7M | 270k | 6.42 | |
| Selecta Biosciences | 0.2 | $1.5M | 546k | 2.66 | |
| Agile Therapeutics | 0.1 | $878k | 1.5M | 0.58 | |
| Trevena | 0.1 | $743k | 1.7M | 0.43 | |
| Foamix Pharmaceuticals | 0.1 | $723k | 202k | 3.59 | |
| Akari Therapeutics | 0.1 | $543k | 346k | 1.57 | |
| Sunesis Pharmaceuticals Inc Ne | 0.0 | $80k | 196k | 0.41 | |
| Soleno Therapeutics, Inc. warrant | 0.0 | $19k | 189k | 0.10 |
